NexBio Reports Positive Data from Test of Biologic Flu Drug
publication date: Aug 30, 2011
NexBio, a San Diego biotech startup, has released positive data from a Phase II trial of a novel biologic that aims to both treat and prevent infection by all flu strains. The drug works by inhibiting entry of the virus into cells. NexBio was formed by a China husband-wife team who did their early academic work in China, and then moved to the US to earn biology PhDs. NexBio has been in the news recently because the FBI conducted a very public raid on the company’s offices, though neither the FBI nor the company has explained the object of the raid. More details....
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.